Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Anti-CD19-CD20 CAR T cells |
Trade Name | |
Synonyms | |
Drug Descriptions |
Anti-CD19-CD20 CAR T-cells are T-cells that are engineered to express a bispecific antibody that targets CD19 and CD20, which potentially results in an anti-tumor immune response against cells expressing either CD19 or CD20 (PMID: 27059623, PMID: 29207878). |
DrugClasses | CD19 Immune Cell Therapy 62 CD20 Immune Cell Therapy 11 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Anti-CD19-CD20 CAR T cells | Anti-CD19-CD20 CAR T cells | 0 | 3 |
Anti-CD19-CD20 CAR T cells + Cyclophosphamide + Fludarabine | Anti-CD19-CD20 CAR T cells Cyclophosphamide Fludarabine | 0 | 1 |